What is the Incorporation or founding date of Solis Pharmachem Private Limited?

Solis Pharmachem Private Limited was incorporated on 03 Dec 2019.

What is authorized share capital and paid-up capital of Solis Pharmachem Private Limited?

The authorized share capital of Solis Pharmachem Private Limited is ₹ 250000000.0 and paid-up capital is ₹ 247579000.0.

Who are the current board members & directors of Solis Pharmachem Private Limited?

Currently 4 directors are associated with Solis Pharmachem Private Limited. Anil Kumar Jain, Mansi Bansal And 2 More.

What is the registered address of Solis Pharmachem Private Limited?

As per Ministry of Corporate Affairs (Mca), the registered address of Solis Pharmachem Private Limited is Plot No. 4707/A/5 Sentogen Plot, Near Lyka Chokdi India, Ankleshwar, Gujarat, 393002.

What is the corporate identification number (CIN) and company number of Solis Pharmachem Private Limited?

The corporate identification number (CIN) of Solis Pharmachem Private Limited is U24100GJ2019PTC111161 and the company number is 111161 as per Ministry of Corporate Affairs (MCA).

What is the official website of Solis Pharmachem Private Limited?

The Official website of Solis Pharmachem Private Limited is https://www.solispharma.in .

What has been the recent revenue trend for Solis Pharmachem Private Limited?

According to the financial reports for the fiscal year 2022, the revenue trend for Solis Pharmachem Private Limited has fallen by -100.00%.

How many employees does Solis Pharmachem Private Limited currently have?

As Per 2022 financial reports, 26 employees are currently employed by Solis Pharmachem Private Limited.

What change has been observed in the net worth of Solis Pharmachem Private Limited, and by what percentage?

The financial reports for the fiscal year 2022 indicates that The net worth of Solis Pharmachem Private Limited has experienced an upsurge of 305.25%.

When was the last Balance Sheet of Solis Pharmachem Private Limited filed with the ROC?

The most recent Balance Sheet for Solis Pharmachem Private Limited was filed with the ROC on 31 Mar 2023.

Solis Pharmachem Private Limited

Solis Pharmachem Profile

Key Indicators

Authorised Capital ₹ 25.00 Cr as on 18-01-2025
Paid Up Capital ₹ 24.76 Cr as on 18-01-2025
Company Age 5 Year, 2 Months
Last Filing with ROC 31 Mar 2023
Revenue Growth -100.00% (FY 2022)
Profit Growth 46.22% (FY 2022)
Ebitda 68.55% (FY 2022)
Net Worth 305.25% (FY 2022)
Total Assets 361.73% (FY 2022)

About Solis Pharmachem

Solis Pharmachem Private Limited (SPPL) is Amalgamated company established on 03 Dec 2019 with its office registered at Vadodara, Gujarat, India and has been running since 5 Year, 2 Months with a paid up capital of 24.76 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 18 Jan 2025.

Company Details

Location

Vadodara, Gujarat, India
Telephone
+91-XXXXXXXXXX
Email Address
Website

solispharma.in
Social Media

-

Corporate Identity Details

CIN/LLPIN
U24100GJ2019PTC111161
Company No.
111161
Company Classification
Private Limited Indian Non-Government Company
Incorporation Date
03 Dec 2019
Date of AGM
02 Aug 2023
Date of Balance Sheet
31 Mar 2023
Listing Status
Unlisted
ROC Code
Roc Ahmedabad

Industry

Chemicals and Materials

Who are the key members and board of directors at Solis Pharmachem?

Executive Team (1)

Name	Designation	Appointment Date	Status
Mansi Bansal	Company Secretary	02-Jun-2023	Current

Board Members (3)

Name	Designation	Appointment Date	Status
Rajnish Sarna	Director	02-Jun-2023	Current
Samir Dhaga	Director	02-Jun-2023	Current
Anil Jain	Director	02-Jun-2023	Current

Financial Performance of Solis Pharmachem.

Solis Pharmachem Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial improvement in profitability, with a 46.22% increase in profit. The company's net worth Soared by an impressive increase of 305.25%.

Graph illustrating revenue growth over time

Graph showing profit and loss trends over time

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

-100.00%

Revenue from Operations

Total Assets

361.73%

Profit or Loss

46.22%

Net Worth

305.25%

EBITDA

68.55%

What is the Ownership and Shareholding Structure of Solis Pharmachem?

Unlock access to Solis Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Charges (Loans)

There are no open charges registered against the company as per our records.

How Many Employees Work at Solis Pharmachem?

Solis Pharmachem has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Solis Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Solis Pharmachem's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Solis Pharmachem Private Limited